ESWT: An FDA-Cleared, Evidence-Based Alternative
Extracorporeal Shock Wave Therapy (ESWT) is not an experimental treatment. The FDA cleared ESWT specifically for the treatment of chronic plantar fasciitis in 2000, and the technology has been refined and studied extensively in the two decades since. The evidence base includes multiple randomized controlled trials documenting success rates of 60 to 80 percent for patients with chronic plantar fasciitis who had failed conservative management.
The Case Against Rushing to Surgery
Surgical plantar fascia release carries a range of risks that are rarely communicated with adequate transparency:
- Injury to the medial calcaneal nerve, causing permanent numbness or painful neuroma formation
- Progressive arch collapse as the plantar fascia's structural role in supporting the arch is compromised
- Lateral column pain from altered weight distribution across the metatarsals
- Infection, wound healing complications, and anesthesia risks
- 6 to 8 weeks of non-weight-bearing immobilization followed by months of physical therapy
Recovery Comparison
Following surgery, most patients spend 6 to 8 weeks non-weight-bearing, followed by 3 to 6 months of physical therapy. Following an ESWT course — 3 sessions over 3 weeks — patients return to normal daily activity immediately. There is no immobilization, no incision, and no prolonged rehabilitation.
Before you agree to foot surgery, schedule a consultation today and let Dr. Katz review whether you are a candidate for shockwave therapy. Explore all treatment options at Katz Regenerative Foot & Ankle.